LRRK2 and Parkinson disease: As a proof-of-principle experiment, we derived an iPSC line from skin biopsies obtained from a PD patient with a defined mutation in LRRK2 as mutations in LRRK2 account for approximately 7% of familial PD cases and a significant portion of sporadic PD cases [24,25].